News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Lipomics Technologies, Inc. To Support Isis Pharmaceuticals, Inc. (ISIS) In Preclinical And Clinical Studies Of Metabolic Drug Candidates


2/14/2007 10:27:30 AM

WEST SACRAMENTO, CA -- (MARKET WIRE) -- February 14, 2007 -- Lipomics Technologies, Inc., a privately held company that specializes in the analysis of lipid metabolites, announced today that it has entered into an agreement with Isis Pharmaceuticals, Inc. to provide lipid-focused support of preclinical and clinical trial testing for various compounds to treat metabolic disease.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES